These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27838604)

  • 41. Role of interleukin-1beta in the development of malnutrition in chronic renal failure patients.
    Maruyama Y; Stenvinkel P; Lindholm B
    Blood Purif; 2005; 23(4):275-81. PubMed ID: 15925866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations of adiponectin and leptin levels with protein-energy wasting, in end stage renal disease patients.
    Markaki A; Grammatikopoulou MG; Venihaki M; Kyriazis J; Perakis K; Stylianou K
    Endocrinol Nutr; 2016 Nov; 63(9):449-457. PubMed ID: 27638461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adiponectin and leptin in chronic kidney disease: causal factors or mere risk markers?
    Zoccali C; Mallamaci F
    J Ren Nutr; 2011 Jan; 21(1):87-91. PubMed ID: 21195927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammation in end-stage renal disease--a fire that burns within.
    Stenvinkel P
    Contrib Nephrol; 2005; 149():185-199. PubMed ID: 15876843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endocrine and metabolic changes affecting cardiovascular disease in dialysis patients.
    Shoji T; Emoto M; Nishizawa Y; Inaba M
    J Ren Nutr; 2015 Mar; 25(2):223-5. PubMed ID: 25556309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The complex role of adiponectin in chronic kidney disease.
    Jia T; Carrero JJ; Lindholm B; Stenvinkel P
    Biochimie; 2012 Oct; 94(10):2150-6. PubMed ID: 22980197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High serum adiponectin levels during steroid-responsive nephrotic syndrome relapse.
    Bakkaloglu SA; Soylemezoglu O; Buyan N; Funahashi T; Elhan AH; Peru H; Fidan K; Yilmaz S; Hasanoglu E
    Pediatr Nephrol; 2005 Apr; 20(4):474-7. PubMed ID: 15690190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.
    Suliman ME; Stenvinkel P; Bárány P; Heimbürger O; Anderstam B; Lindholm B
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S89-95. PubMed ID: 12612961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases.
    Choi HM; Doss HM; Kim KS
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of the novel adipocyte-derived protein adiponectin in human disease: an update.
    Díez JJ; Iglesias P
    Mini Rev Med Chem; 2010 Aug; 10(9):856-69. PubMed ID: 20482500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Energy intake and energy expenditure profiles in peritoneal dialysis patients.
    Wang AY
    J Ren Nutr; 2011 Jan; 21(1):31-4. PubMed ID: 21195915
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
    Chu PL; Chiu YL; Lin JW; Chen SI; Wu KD
    Blood Purif; 2008; 26(2):213-20. PubMed ID: 18285698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Markers of endocrine system and inflammation as prognostic risk factors of vascular complications of type 2 diabetes mellitus].
    Verbovoĭ AF; Morkovskikh NV
    Vestn Ross Akad Med Nauk; 2011; (3):37-42. PubMed ID: 21542374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study.
    Akdag I; Yilmaz Y; Kahvecioglu S; Bolca N; Ercan I; Ersoy A; Gullulu M
    Nephron Clin Pract; 2008; 108(2):c99-c105. PubMed ID: 18212491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adiponectin, obesity, and cardiovascular disease.
    Fasshauer M; Paschke R; Stumvoll M
    Biochimie; 2004 Nov; 86(11):779-84. PubMed ID: 15589686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
    Yamauchi T; Kadowaki T
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is ghrelin a biomarker for mortality in end-stage renal disease?
    Mak RH; Cheung WW
    Kidney Int; 2011 Apr; 79(7):697-9. PubMed ID: 21403653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular disease in end stage renal disease.
    Sharma R; Pellerin D; Brecker SJ
    Minerva Urol Nefrol; 2006 Jun; 58(2):117-31. PubMed ID: 16767066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adiponectin Fractions Influence the Development of Posttransplant Diabetes Mellitus and Cardiovascular Disease in Japanese Renal Transplant Recipients.
    Adachi H; Nakayama K; Hayashi N; Matsui Y; Fujimoto K; Yamaya H; Tonami H; Yokoyama H
    PLoS One; 2016; 11(10):e0163899. PubMed ID: 27706207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adiponectin in renal disease--a review of the evidence as a risk factor for cardiovascular and all-cause mortality.
    Connelly PW; Ramesh Prasad GV
    Crit Rev Clin Lab Sci; 2012; 49(5-6):218-31. PubMed ID: 23216078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.